Molly Lamb
Concepts (394)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Development | 6 | 2025 | 484 | 1.620 |
Why?
| | Muscular Dystrophy, Duchenne | 6 | 2022 | 91 | 1.540 |
Why?
| | Rural Population | 17 | 2025 | 650 | 1.500 |
Why?
| | Head | 2 | 2025 | 120 | 1.480 |
Why?
| | Guatemala | 28 | 2025 | 345 | 1.410 |
Why?
| | Zika Virus Infection | 6 | 2024 | 168 | 1.270 |
Why?
| | Diet | 11 | 2024 | 1275 | 1.230 |
Why?
| | Autoimmunity | 8 | 2020 | 927 | 1.100 |
Why?
| | Islets of Langerhans | 6 | 2014 | 833 | 0.980 |
Why?
| | Zika Virus | 4 | 2024 | 132 | 0.930 |
Why?
| | Dengue | 2 | 2024 | 89 | 0.890 |
Why?
| | Influenza, Human | 7 | 2025 | 617 | 0.830 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2020 | 3890 | 0.810 |
Why?
| | Infant | 38 | 2025 | 10039 | 0.780 |
Why?
| | Dengue Virus | 2 | 2024 | 58 | 0.770 |
Why?
| | Body Weight | 2 | 2018 | 978 | 0.760 |
Why?
| | Growth Disorders | 2 | 2023 | 86 | 0.760 |
Why?
| | Body Height | 2 | 2016 | 202 | 0.710 |
Why?
| | Child | 48 | 2025 | 22657 | 0.690 |
Why?
| | Child, Preschool | 38 | 2025 | 11799 | 0.670 |
Why?
| | Infant, Newborn | 18 | 2025 | 6434 | 0.550 |
Why?
| | Microcephaly | 4 | 2024 | 103 | 0.530 |
Why?
| | Child Nutritional Physiological Phenomena | 3 | 2015 | 106 | 0.510 |
Why?
| | Humans | 91 | 2026 | 144957 | 0.500 |
Why?
| | Dietary Carbohydrates | 2 | 2015 | 151 | 0.480 |
Why?
| | Pregnenediones | 1 | 2016 | 14 | 0.480 |
Why?
| | Prospective Studies | 18 | 2025 | 7997 | 0.480 |
Why?
| | Milk | 2 | 2014 | 119 | 0.450 |
Why?
| | HLA-DR Antigens | 2 | 2014 | 220 | 0.450 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 479 | 0.450 |
Why?
| | Carbohydrates | 1 | 2015 | 66 | 0.440 |
Why?
| | Prednisone | 1 | 2016 | 221 | 0.440 |
Why?
| | Carbonic Anhydrases | 2 | 2005 | 12 | 0.440 |
Why?
| | Culicidae | 2 | 2005 | 33 | 0.430 |
Why?
| | Male | 49 | 2025 | 72406 | 0.390 |
Why?
| | Eating | 2 | 2024 | 392 | 0.380 |
Why?
| | Body Mass Index | 8 | 2020 | 2438 | 0.380 |
Why?
| | Oryza | 2 | 2024 | 32 | 0.370 |
Why?
| | Disease Progression | 4 | 2015 | 2852 | 0.370 |
Why?
| | Infant Food | 2 | 2015 | 64 | 0.370 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2025 | 54 | 0.360 |
Why?
| | Female | 53 | 2025 | 78376 | 0.360 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 136 | 0.360 |
Why?
| | Viruses | 3 | 2023 | 165 | 0.360 |
Why?
| | Developing Countries | 3 | 2025 | 318 | 0.360 |
Why?
| | Cross-Sectional Studies | 10 | 2025 | 5872 | 0.350 |
Why?
| | Sarcoma, Kaposi | 2 | 2023 | 83 | 0.350 |
Why?
| | Cohort Studies | 10 | 2025 | 5965 | 0.350 |
Why?
| | Seroepidemiologic Studies | 5 | 2023 | 172 | 0.350 |
Why?
| | Glucocorticoids | 1 | 2016 | 535 | 0.350 |
Why?
| | Immunoglobulin G | 3 | 2022 | 893 | 0.340 |
Why?
| | Global Health | 2 | 2025 | 401 | 0.340 |
Why?
| | Audiovisual Aids | 1 | 2010 | 11 | 0.330 |
Why?
| | Sexual Maturation | 1 | 2010 | 51 | 0.330 |
Why?
| | Hyperlipidemias | 1 | 2011 | 122 | 0.320 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 93 | 0.320 |
Why?
| | School Teachers | 3 | 2025 | 29 | 0.310 |
Why?
| | Pregnancy | 12 | 2024 | 7191 | 0.310 |
Why?
| | Virus Diseases | 2 | 2022 | 216 | 0.300 |
Why?
| | Antibodies, Viral | 6 | 2023 | 672 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1416 | 0.300 |
Why?
| | Overweight | 3 | 2019 | 609 | 0.290 |
Why?
| | Self Concept | 1 | 2010 | 253 | 0.290 |
Why?
| | Risk Factors | 13 | 2025 | 10792 | 0.280 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2005 | 14 | 0.280 |
Why?
| | Meningitis, Bacterial | 2 | 2022 | 45 | 0.280 |
Why?
| | Glycemic Index | 1 | 2008 | 26 | 0.280 |
Why?
| | Adolescent | 21 | 2025 | 22453 | 0.280 |
Why?
| | Autoantibodies | 5 | 2020 | 1504 | 0.280 |
Why?
| | Delivery, Obstetric | 2 | 2019 | 160 | 0.280 |
Why?
| | Obesity | 5 | 2015 | 3082 | 0.270 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 18 | 0.270 |
Why?
| | Norovirus | 2 | 2018 | 22 | 0.260 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6053 | 0.260 |
Why?
| | Body Composition | 1 | 2011 | 706 | 0.260 |
Why?
| | Respiratory Tract Infections | 2 | 2022 | 398 | 0.260 |
Why?
| | Viral Vaccines | 2 | 2018 | 107 | 0.260 |
Why?
| | Caregivers | 3 | 2021 | 1049 | 0.250 |
Why?
| | Psychology, Child | 1 | 2007 | 37 | 0.250 |
Why?
| | Vaccination | 3 | 2025 | 1423 | 0.250 |
Why?
| | Lipids | 2 | 2011 | 710 | 0.250 |
Why?
| | Gastroenteritis | 2 | 2017 | 63 | 0.250 |
Why?
| | Adipose Tissue | 1 | 2011 | 653 | 0.250 |
Why?
| | Genotype | 4 | 2015 | 1835 | 0.250 |
Why?
| | Interviews as Topic | 1 | 2010 | 901 | 0.250 |
Why?
| | Herpesvirus 8, Human | 2 | 2023 | 68 | 0.240 |
Why?
| | Adult | 22 | 2025 | 40506 | 0.240 |
Why?
| | Mental Health Services | 2 | 2021 | 474 | 0.230 |
Why?
| | Young Adult | 16 | 2025 | 14126 | 0.230 |
Why?
| | Blood Culture | 1 | 2025 | 25 | 0.220 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 81 | 0.220 |
Why?
| | Ectoparasitic Infestations | 1 | 2024 | 5 | 0.220 |
Why?
| | Schools | 4 | 2023 | 453 | 0.220 |
Why?
| | Gastrointestinal Tract | 2 | 2019 | 208 | 0.220 |
Why?
| | Masks | 2 | 2022 | 70 | 0.220 |
Why?
| | Animals, Domestic | 1 | 2024 | 17 | 0.220 |
Why?
| | Nasopharynx | 1 | 2025 | 73 | 0.220 |
Why?
| | Digestive System | 1 | 2004 | 28 | 0.210 |
Why?
| | Niacin | 1 | 2024 | 16 | 0.210 |
Why?
| | Income | 1 | 2025 | 202 | 0.210 |
Why?
| | Culex | 1 | 2023 | 14 | 0.200 |
Why?
| | Psychotherapy | 1 | 2025 | 191 | 0.200 |
Why?
| | Educational Personnel | 1 | 2023 | 11 | 0.200 |
Why?
| | Coinfection | 2 | 2022 | 141 | 0.200 |
Why?
| | Saliva | 1 | 2025 | 249 | 0.200 |
Why?
| | Antimicrobial Stewardship | 1 | 2025 | 130 | 0.190 |
Why?
| | HIV Seropositivity | 1 | 2023 | 119 | 0.190 |
Why?
| | Aedes | 1 | 2023 | 65 | 0.190 |
Why?
| | Public Health | 2 | 2026 | 566 | 0.190 |
Why?
| | Bacteremia | 1 | 2025 | 221 | 0.190 |
Why?
| | Metapneumovirus | 1 | 2022 | 15 | 0.190 |
Why?
| | Cross Reactions | 1 | 2022 | 130 | 0.190 |
Why?
| | Diarrhea | 2 | 2023 | 192 | 0.180 |
Why?
| | Cephalometry | 1 | 2022 | 30 | 0.180 |
Why?
| | Anthropometry | 1 | 2022 | 200 | 0.180 |
Why?
| | Erythrocyte Membrane | 2 | 2015 | 54 | 0.170 |
Why?
| | Prevalence | 8 | 2021 | 2836 | 0.170 |
Why?
| | Parents | 3 | 2023 | 1403 | 0.170 |
Why?
| | Family Health | 2 | 2015 | 191 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 227 | 0.170 |
Why?
| | Sexually Transmitted Diseases, Viral | 1 | 2021 | 11 | 0.170 |
Why?
| | Lead Poisoning | 1 | 2021 | 17 | 0.170 |
Why?
| | Meningitis | 1 | 2022 | 80 | 0.170 |
Why?
| | Pandemics | 3 | 2025 | 1695 | 0.170 |
Why?
| | Health Literacy | 1 | 2023 | 184 | 0.170 |
Why?
| | Cesarean Section | 2 | 2019 | 224 | 0.170 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1325 | 0.160 |
Why?
| | Arsenic | 1 | 2021 | 66 | 0.160 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1327 | 0.160 |
Why?
| | Midwifery | 1 | 2022 | 64 | 0.160 |
Why?
| | Emergency Responders | 1 | 2021 | 37 | 0.160 |
Why?
| | Motivation | 1 | 2025 | 610 | 0.160 |
Why?
| | Malaria | 1 | 2021 | 73 | 0.160 |
Why?
| | Birth Intervals | 1 | 2020 | 23 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2015 | 142 | 0.160 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 104 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 851 | 0.160 |
Why?
| | Lysine | 1 | 2022 | 302 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2022 | 102 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2020 | 83 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 186 | 0.160 |
Why?
| | Cesarean Section, Repeat | 1 | 2019 | 11 | 0.160 |
Why?
| | Regression Analysis | 1 | 2022 | 1003 | 0.150 |
Why?
| | Age of Onset | 4 | 2022 | 551 | 0.150 |
Why?
| | Vaginal Birth after Cesarean | 1 | 2019 | 27 | 0.150 |
Why?
| | Language Tests | 1 | 2019 | 23 | 0.150 |
Why?
| | Refugees | 1 | 2021 | 83 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5417 | 0.150 |
Why?
| | Breast Feeding | 4 | 2015 | 448 | 0.150 |
Why?
| | Population Surveillance | 2 | 2026 | 485 | 0.150 |
Why?
| | Language Development Disorders | 1 | 2019 | 40 | 0.150 |
Why?
| | Sexual Partners | 1 | 2021 | 192 | 0.150 |
Why?
| | Dietary Proteins | 2 | 2013 | 136 | 0.150 |
Why?
| | Motor Skills | 1 | 2020 | 104 | 0.140 |
Why?
| | Adolescent Health | 1 | 2019 | 37 | 0.140 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2021 | 285 | 0.140 |
Why?
| | Social Class | 2 | 2010 | 268 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 30 | 0.140 |
Why?
| | Arbovirus Infections | 1 | 2018 | 20 | 0.140 |
Why?
| | Sensitivity and Specificity | 5 | 2025 | 1990 | 0.140 |
Why?
| | Public Health Surveillance | 1 | 2018 | 83 | 0.140 |
Why?
| | Sexual Behavior | 2 | 2021 | 492 | 0.140 |
Why?
| | HLA-DQ beta-Chains | 2 | 2015 | 57 | 0.140 |
Why?
| | HLA-DR4 Antigen | 2 | 2015 | 74 | 0.140 |
Why?
| | HLA-DR3 Antigen | 2 | 2015 | 76 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 428 | 0.140 |
Why?
| | Linear Models | 3 | 2023 | 854 | 0.140 |
Why?
| | Vaccines | 1 | 2023 | 389 | 0.130 |
Why?
| | Epilepsy | 1 | 2022 | 387 | 0.130 |
Why?
| | Sentinel Surveillance | 1 | 2017 | 46 | 0.130 |
Why?
| | Emergency Service, Hospital | 4 | 2022 | 2313 | 0.130 |
Why?
| | Medicaid | 1 | 2021 | 462 | 0.130 |
Why?
| | Celiac Disease | 1 | 2020 | 308 | 0.130 |
Why?
| | Sex Factors | 4 | 2010 | 2114 | 0.120 |
Why?
| | Cell Phone | 1 | 2017 | 82 | 0.120 |
Why?
| | Family Characteristics | 4 | 2021 | 197 | 0.120 |
Why?
| | Biomarkers | 3 | 2025 | 4275 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 491 | 0.120 |
Why?
| | Micronutrients | 2 | 2007 | 96 | 0.120 |
Why?
| | Mental Disorders | 1 | 2025 | 1172 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 529 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3415 | 0.120 |
Why?
| | Fever | 1 | 2017 | 312 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 178 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 130 | 0.110 |
Why?
| | Feeding Methods | 1 | 2015 | 5 | 0.110 |
Why?
| | F2-Isoprostanes | 1 | 2015 | 20 | 0.110 |
Why?
| | Learning | 1 | 2020 | 452 | 0.110 |
Why?
| | Models, Psychological | 1 | 2017 | 299 | 0.110 |
Why?
| | Methazolamide | 2 | 2005 | 5 | 0.110 |
Why?
| | Animals | 9 | 2026 | 38109 | 0.110 |
Why?
| | Oxygen Isotopes | 2 | 2005 | 24 | 0.110 |
Why?
| | Acetazolamide | 2 | 2005 | 26 | 0.110 |
Why?
| | Histocytochemistry | 2 | 2005 | 79 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2015 | 58 | 0.110 |
Why?
| | Mobile Applications | 1 | 2017 | 196 | 0.110 |
Why?
| | Energy Intake | 2 | 2008 | 500 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1915 | 0.110 |
Why?
| | District of Columbia | 2 | 2012 | 36 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 534 | 0.110 |
Why?
| | Food Supply | 1 | 2015 | 90 | 0.100 |
Why?
| | Chickens | 2 | 2024 | 191 | 0.100 |
Why?
| | Age Factors | 5 | 2015 | 3335 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 501 | 0.100 |
Why?
| | Walking | 1 | 2018 | 545 | 0.100 |
Why?
| | Species Specificity | 2 | 2005 | 574 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 561 | 0.100 |
Why?
| | United States | 9 | 2021 | 15988 | 0.100 |
Why?
| | Health Behavior | 1 | 2019 | 786 | 0.100 |
Why?
| | India | 2 | 2025 | 218 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2021 | 3608 | 0.090 |
Why?
| | Social Support | 1 | 2017 | 652 | 0.090 |
Why?
| | Seroconversion | 2 | 2023 | 49 | 0.090 |
Why?
| | Kenya | 2 | 2023 | 129 | 0.090 |
Why?
| | Contact Tracing | 1 | 2012 | 26 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 348 | 0.090 |
Why?
| | Psychometrics | 3 | 2021 | 734 | 0.090 |
Why?
| | Transportation | 1 | 2012 | 54 | 0.090 |
Why?
| | Personal Protective Equipment | 2 | 2022 | 57 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2032 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 886 | 0.090 |
Why?
| | Insulin | 2 | 2015 | 2507 | 0.090 |
Why?
| | Quality Improvement | 4 | 2022 | 1291 | 0.090 |
Why?
| | Mass Spectrometry | 2 | 2005 | 750 | 0.090 |
Why?
| | HLA Antigens | 2 | 2013 | 225 | 0.080 |
Why?
| | Cattle | 1 | 2014 | 1000 | 0.080 |
Why?
| | Area Under Curve | 2 | 2009 | 331 | 0.080 |
Why?
| | Acute Disease | 3 | 2019 | 1031 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2012 | 131 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 589 | 0.080 |
Why?
| | Nutrition Surveys | 4 | 2015 | 282 | 0.080 |
Why?
| | ROC Curve | 2 | 2009 | 615 | 0.080 |
Why?
| | Fetal Weight | 1 | 2009 | 54 | 0.080 |
Why?
| | Pilot Projects | 2 | 2025 | 1890 | 0.070 |
Why?
| | Chikungunya Fever | 2 | 2021 | 84 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 3192 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 337 | 0.070 |
Why?
| | Colorado | 3 | 2026 | 4564 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2017 | 1153 | 0.070 |
Why?
| | Solanum tuberosum | 1 | 2008 | 8 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3154 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 17101 | 0.070 |
Why?
| | Edible Grain | 1 | 2008 | 49 | 0.070 |
Why?
| | Bias | 1 | 2009 | 202 | 0.070 |
Why?
| | Pregnancy in Diabetics | 1 | 2009 | 121 | 0.070 |
Why?
| | Middle Aged | 8 | 2025 | 35928 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2009 | 175 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 685 | 0.070 |
Why?
| | Radiographic Image Enhancement | 1 | 2007 | 57 | 0.060 |
Why?
| | Self Disclosure | 1 | 2007 | 62 | 0.060 |
Why?
| | Vegetables | 1 | 2008 | 170 | 0.060 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2947 | 0.060 |
Why?
| | Vitamins | 2 | 2024 | 178 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 522 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2010 | 1095 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 975 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2007 | 427 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2147 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1540 | 0.060 |
Why?
| | Glucagon-Like Peptide 2 | 1 | 2025 | 7 | 0.060 |
Why?
| | Mammography | 1 | 2007 | 166 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 559 | 0.060 |
Why?
| | Mental Health | 2 | 2023 | 792 | 0.060 |
Why?
| | Risk | 2 | 2021 | 911 | 0.060 |
Why?
| | West Nile Fever | 1 | 2026 | 57 | 0.060 |
Why?
| | Students | 2 | 2023 | 663 | 0.060 |
Why?
| | Influenza B virus | 1 | 2025 | 47 | 0.060 |
Why?
| | Anaplasma | 1 | 2024 | 3 | 0.060 |
Why?
| | Ehrlichia | 1 | 2024 | 4 | 0.060 |
Why?
| | Bartonella | 1 | 2024 | 8 | 0.060 |
Why?
| | Rickettsia | 1 | 2024 | 11 | 0.060 |
Why?
| | Siphonaptera | 1 | 2024 | 14 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2013 | 2365 | 0.060 |
Why?
| | Mental Recall | 1 | 2007 | 222 | 0.060 |
Why?
| | Dietary Fats | 1 | 2007 | 315 | 0.050 |
Why?
| | Ticks | 1 | 2024 | 29 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1137 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2007 | 233 | 0.050 |
Why?
| | Cats | 1 | 2024 | 228 | 0.050 |
Why?
| | Influenza A virus | 1 | 2025 | 113 | 0.050 |
Why?
| | Nutritional Status | 1 | 2007 | 354 | 0.050 |
Why?
| | Prognosis | 1 | 2013 | 4293 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 70 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 732 | 0.050 |
Why?
| | Mosquito Vectors | 1 | 2023 | 28 | 0.050 |
Why?
| | Magnesium | 1 | 2024 | 155 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 438 | 0.050 |
Why?
| | Larva | 1 | 2004 | 242 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1486 | 0.050 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2009 | 675 | 0.050 |
Why?
| | Pyridoxine | 1 | 2022 | 37 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8279 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 130 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 48 | 0.050 |
Why?
| | Cough | 1 | 2023 | 124 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 129 | 0.050 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2022 | 99 | 0.050 |
Why?
| | Swine | 1 | 2024 | 833 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 293 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 105 | 0.040 |
Why?
| | Fermentation | 1 | 2021 | 32 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 316 | 0.040 |
Why?
| | Phenotype | 2 | 2022 | 3164 | 0.040 |
Why?
| | Food Contamination | 1 | 2021 | 56 | 0.040 |
Why?
| | Methylene Blue | 1 | 2021 | 24 | 0.040 |
Why?
| | Equipment Reuse | 1 | 2021 | 18 | 0.040 |
Why?
| | Decontamination | 1 | 2021 | 32 | 0.040 |
Why?
| | Immunization | 1 | 2023 | 374 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 261 | 0.040 |
Why?
| | Hospitalization | 2 | 2022 | 2434 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 50 | 0.040 |
Why?
| | Hot Temperature | 1 | 2024 | 407 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 175 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 130 | 0.040 |
Why?
| | Brazil | 1 | 2021 | 180 | 0.040 |
Why?
| | Lead | 1 | 2021 | 70 | 0.040 |
Why?
| | Diet Surveys | 2 | 2013 | 91 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 284 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 521 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 53 | 0.040 |
Why?
| | Translations | 1 | 2020 | 18 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1348 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 173 | 0.040 |
Why?
| | Chikungunya virus | 1 | 2021 | 86 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 175 | 0.040 |
Why?
| | Parity | 1 | 2019 | 109 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 307 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 21 | 0.040 |
Why?
| | Translating | 1 | 2019 | 50 | 0.040 |
Why?
| | Triage | 1 | 2021 | 249 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 87 | 0.040 |
Why?
| | Parasites | 1 | 2019 | 44 | 0.040 |
Why?
| | Dengue Vaccines | 1 | 2018 | 11 | 0.040 |
Why?
| | Arboviruses | 1 | 2018 | 14 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 74 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 99 | 0.030 |
Why?
| | RNA, Viral | 1 | 2022 | 688 | 0.030 |
Why?
| | Seasons | 1 | 2021 | 556 | 0.030 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 84 | 0.030 |
Why?
| | Blood Glucose | 1 | 2008 | 2330 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 529 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 113 | 0.030 |
Why?
| | Proteins | 1 | 2004 | 1022 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 242 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2019 | 177 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 178 | 0.030 |
Why?
| | Child Health | 1 | 2019 | 157 | 0.030 |
Why?
| | Mothers | 1 | 2023 | 775 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 473 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 476 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 189 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 518 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2021 | 603 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 75 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1049 | 0.030 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2118 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1137 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2119 | 0.030 |
Why?
| | Risk-Taking | 1 | 2019 | 328 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 147 | 0.030 |
Why?
| | Aged | 3 | 2025 | 25947 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 948 | 0.030 |
Why?
| | Data Collection | 1 | 2018 | 635 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 99 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 697 | 0.030 |
Why?
| | Cities | 1 | 2015 | 143 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2456 | 0.030 |
Why?
| | Cognition | 1 | 2022 | 1269 | 0.030 |
Why?
| | Bacteria | 1 | 2019 | 889 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 331 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7183 | 0.020 |
Why?
| | Health Promotion | 1 | 2019 | 774 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2925 | 0.020 |
Why?
| | Automobiles | 1 | 2012 | 18 | 0.020 |
Why?
| | Virginia | 1 | 2012 | 55 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 66 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 373 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1385 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1660 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3676 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 717 | 0.020 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 96 | 0.020 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2007 | 48 | 0.020 |
Why?
| | Environmental Exposure | 1 | 2012 | 590 | 0.020 |
Why?
| | Carotenoids | 1 | 2007 | 48 | 0.020 |
Why?
| | Research Personnel | 1 | 2009 | 186 | 0.020 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2007 | 149 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 682 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2009 | 456 | 0.010 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 466 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1054 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|